CPIM
ENZ

Columbia Partners Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Columbia Partners Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-755,405
Closed -$3.35M – 365
2014
Q4 		$3.35M Sell
755,405
-22,951
-3% -$109K 0.17% 160
2014
Q3 		$4.01M Buy
778,356
+64,072
+9% +$342K 0.2% 146
2014
Q2 		$3.75M Buy
714,284
+426,111
+148% +$1.84M 0.17% 169
2014
Q1 		$1.2M Buy
+288,173
New +$988K 0.05% 234

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Columbia Partners Investment Management's ENZ Position: Q1 2015 in Review

Columbia Partners Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2015, closing a stake of 755,405 shares — an estimated $3.35M sold.

Columbia Partners Investment Management first reported a position in ENZ in Q1 2014 and held it in 4 quarters. The position peaked at $4.01M in Q3 2014. 90 funds tracked by Wall St. Rank hold ENZ as of Q1 2015.

  • Columbia Partners Investment Management reported no remaining Enzo Biochem, Inc. position as of Q1 2015 after selling out during the quarter.
  • Columbia Partners Investment Management sold 755,405 Enzo Biochem, Inc. shares in Q1 2015, an estimated $3.35M.
  • Columbia Partners Investment Management first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 4 quarters.
  • Columbia Partners Investment Management's Enzo Biochem, Inc. position peaked at $4.01M in Q3 2014.
  • 90 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2015.

Based on Columbia Partners Investment Management's 13F filing for Q1 2015, filed 13 May 2015.